‘Significant’ risk to dispensing SA’s unregistered Ivermectin

 

Medical Brief (24 February 2021) reported that four out of five Ivermectin tablets tested in South Africa had at least one unregistered active pharmaceutical ingredient. According to a small study, published in the SA Medical Journal there are “significant potential safety concerns for patients (and) consequent legal ramifications for the dispenser and/or prescribing doctor”.

According to the researchers the anecdotal evidence of successful COVID-19 treatment with Ivermectin formulations may be confounded by the possible intentional addition of these undeclared medications to target and alleviate COVID-19 symptoms.

Other news